Advancing Life Sciences
We focus on high-potential life science opportunities, helping to turn cutting-edge innovations into breakthrough therapies that improve lives and benefit society.
The Eir Ventures team has a truly international experience base and we have committed our entire professional lives to impacting people’s health by engaging in innovative medicine that has the potential to prevent, cure or alleviate disease.
Nordic Innovation
We work closely with our portfolio companies, providing strategic guidance, leveraging our extensive network, and ensuring capital efficiency to accelerate growth. Our hands-on approach helps companies navigate key milestones and by optimizing exit strategies and syndicating investments, we create strong pathways for value realization, aligning with the current needs and maximizing returns for our investors, while contributing to a healthier society.
With Nordic innovation as our foundation and a global perspective as our ambition, Eir Ventures is shaping the future of healthcare.
Exceptional dealflow
Eir Ventures has access to exceptional deal flow, enabled by decades of experience in the life sciences ecosystem and venture capital. The team benefits from an extensive network of top researchers, advisors, and investors. Additionally, we collaborate with leading incubators and actively engage in industry events.
With unique investments from six Swedish medical universities and the University of Copenhagen, Eir Ventures leverages groundbreaking research and strong partnerships to source high-potential opportunities.
Our investment strategy
Eir Ventures’ investment strategy is built on a balanced approach. The strategy leverages investments across a spectrum of opportunities, from mature, lower-risk companies to highly innovative, early-stage projects.
The core idea is to use a strong base of established companies as a foundation for more steady returns and stability. At the same time, Eir Ventures invests in early-stage opportunities, at pre-seed, seed stage or company creation. These investments, while riskier, offer the potential for significant breakthroughs and high returns.
By combining these elements, Eir Ventures balances the lower risk of existing companies with the high potential of emerging innovations, creating a dynamic and adaptable portfolio that captures value across the life sciences spectrum. This strategy supports both financial returns and the advancement of impactful healthcare solutions
Strong investor base
Eir Ventures is backed by leading local and international institutional investors and, uniquely, by leading Nordic universities.
Eir – the goddess of health
The name Eir is inspired by the Norse goddess Eir, known for her healing, mercy, and deep medical knowledge.
In Old Norse mythology, she is often considered one of the Ásynjur (the female deities of the Aesir). And her association with healing, mercy, and life-saving knowledge makes her an important figure in the old Norse mythology, particularly in relation to health and well-being.
Eir Ventures, like the goddess Eir, strives to improve lives by advancing medical innovation, supporting breakthrough therapies, and driving progress in healthcare